Natural killer cells in the late decades of human life

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 269-275

  Ogata, Kiyoyuki ^a   Yokose, Norio ^a   Tamura, Hideto ^a   An, Emi ^a   Nakamura, Kyoko ^a   Dan, Kazuo ^a   Nomura, Takeo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CELL ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFECTION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MORTALITY; NATURAL KILLER CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031240062     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4401     Document Type: Article

References (35)

1. Welsh R. M. Regulation of virus infections by natural killer cells. Nat. Immunol. Cell Growth Regul. 5:1986;169-199.
2. Garcia P. P., Koster F. T., Kelley R. O., McDowell T. D., Bankhurst A. D. Antibacterial activity of human natural killer cells. J. Exp. Med. 169:1989;99-113.
3. Hidore M. R., Murphy J. W. Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans. Infect. Immunol. 57:1989;1990-1997.
4. Fleisher G., Starr S., Koven N., Kamiya H., Douglas S. D., Henle W. A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J. Pediatr. 100:1982;727-730.
5. Biron C. A., Byron K. S., Sullivan J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1989;1731-1735.
6. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E., Fagiolo U., Passeri M., Franceschi C. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
7. Pawelec G., Adibzadeh M., Pohla H., Schaudt K. Immunosenescence: Ageing of the immune system. Immunol. Today. 16:1995;420-422.
8. Ogata K., Tamura H., Yokose N., Dan K., Nomura T. CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people. Lancet. 347:1996;1408.
9. Ligthart G. J., Corberand J. X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller H. H., Steinmann G. G. Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech. Ageing Dev. 28:1984;47-55.
10. Ogata K., Yokose N., Ito T., An E., Tamura H., Dan K., Hamaguchi H., Sakamaki H., Onozawa Y., Nomura T. Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromes. Br. J. Haematol. 86:1994;562-567.
11. Ogata K., Tamura H., Yokose N., An E., Dan K., Hamaguchi H., Sakamaki H., Onozawa Y., Clark S. C., Nomura T. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes. Br. J. Haematol. 90:1995;15-21.
12. Babior B. M., Cohen H. J. Isolation of human neutrophils. Methods in Hematology. 1981;Churchill Livingstone, New York. p. 2-3.
13. Whiteside T. L., Bryant J., Day R., Herberman R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay. J. Clin. Lab. Anal. 4:1990;102-114.
14. H. Tamura, K. Ogata, N. Yokose, E. An, A. Tatsukuchi, K. Kamikubo, K. Dan, H. Hamaguchi, H. Sakamaki, Y. Onozawa, S. C. Clark, T. Nomura, 1995, Effects of cytokines on lymphocyte cytotoxicity in patients with myelodysplastic syndromes, Myelodysplastic Syndromes: Advances in Research and Treatment, T. NomuraY. Yoshida, 369, 373, Elsevier Science, Amsterdam.
15. Phillips J. H., Lanier L. L. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164:1986;814-825.
16. H. C. Lane, G. Whalen, A. S. Fauci, 1986, In vitro evaluation of human lymphocyte function, Handbook of Experimental Immunology, D. M. WeirL. A. HerzenbergC. BlackwellL. A. Herzenberg, 66.1, 66.14, Blackwell Scientific, Oxford.
17. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:1993;759-765.
18. Park B. H., Fikrig S. M., Smithwick E. M. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet. 2:1968;532-534.
19. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:1973;387-410.
20. Facchini A., Mariani E., Mariani A. R., Papa S., Vitale M., Manzoli F. A. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin. Exp. Immunol. 68:1987;340-347.
21. Krishnaraj R., Blandford G. Age-associated alterations in human natural killer cells. 2. Increased frequency of selective NK subsets. Cell. Immunol. 114:1988;137-148.
22. Ligthart G. J., Schuit H. R., Hijmans W. Subpopulations of mononuclear cells in ageing: Expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology. 55:1985;15-21.
23. Tilden A. B., Grossi C. E., Itoh K., Cloud G. A., Dougherty P. A., Balch C. M. Subpopulation analysis of human granular lymphocytes: Associations with age, gender and cytotoxic activity. Nat. Immunol. Cell Growth Regul. 5:1986;90-99.
24. Yamakido M., Yanagida J., Ishioka S., Matsuzaka S., Hozawa S., Akiyama M., Kobuke K., Inamizu T., Nishimoto Y. Detection of lymphocyte subsets by monoclonal antibodies in aged and young humans. Hiroshima J. Med. Sci. 34:1985;87-94.
25. Batory G., Benczur M., Varga M., Garam T., Onody C., Petranyi G. G. Increased killer cell activity in aged humans. Immunobiology. 158:1981;393-402.
26. Bender B. S., Chrest F. J., Adler W. H. Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans. J. Clin. Lab. Immunol. 21:1986;31-36.
27. Fernandes G., Gupta S. Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J. Clin. Immunol. 1:1981;141-148.
28. Krishnaraj R., Blandford G. Age-associated alterations in human natural killer cells. 1. Increased activity as per conventional and kinetic analysis. Clin. Immunol. Immunopathol. 45:1987;268-285.
29. Mysliwska J., Mysliwski A., Romanowski P., Bigda J., Sosnowska D., Foerster J. Monocytes are responsible for depressed natural killer (NK) activity in both young and elderly low NK responders. Gerontology. 38:1992;41-49.
30. Nagel J. E., Collins G. D., Adler W. H. Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients. Cancer Res. 41:1981;2284-2288.
31. Ligthart G. J., Schuit H. R., Hijmans W. Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology. 68:1989;396-402.
32. Vitale M., Zamai L., Neri L. M., Galanzi A., Facchini A., Rana R., Cataldi A., Papa S. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell. Immunol. 145:1992;1-10.
33. Pedersen B. K., Bruunsgaard H. How physical exercise influences the establishment of infections. Sports Med. 19:1995;393-400.
34. Kos F. J., Engleman E. G. Requirement for natural killer cells in the induction of cytotoxic T cells. J. Immunol. 155:1995;578-584.
35. Olshansky S. J., Carnes B. A., Cassel C. In search of Methuselah: Estimating the upper limits to human longevity. Science. 250:1990;634-640.